Orchestra BioMed Holdings Inc (NASDAQ: OBIO) kicked off On Friday, down -20.26% from the previous trading day, before settling in for the closing price of $3.06. Over the past 52 weeks, OBIO has traded in a range of $2.37-$7.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -273.68% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -21.28%. With a float of $26.91 million, this company’s outstanding shares have now reached $38.31 million.
In an organization with 70 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 92.58%, operating margin of -2383.89%, and the pretax margin is -2297.85%.
Orchestra BioMed Holdings Inc (OBIO) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Orchestra BioMed Holdings Inc is 30.35%, while institutional ownership is 49.62%. The most recent insider transaction that took place on Jun 26 ’25, was worth 8,183. In this transaction Director of this company sold 2,683 shares at a rate of $3.05, taking the stock ownership to the 50,949 shares. Before that another transaction happened on Jun 26 ’25, when Company’s Director proposed sale 2,683 for $3.05, making the entire transaction worth $8,194.
Orchestra BioMed Holdings Inc (OBIO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -21.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.75% during the next five years compared to -273.68% drop over the previous five years of trading.
Orchestra BioMed Holdings Inc (NASDAQ: OBIO) Trading Performance Indicators
Take a look at Orchestra BioMed Holdings Inc’s (OBIO) current performance indicators. Last quarter, stock had a quick ratio of 3.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 32.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.77, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -1.77 in one year’s time.
Technical Analysis of Orchestra BioMed Holdings Inc (OBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.51 million. That was better than the volume of 0.28 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 14.96%.
During the past 100 days, Orchestra BioMed Holdings Inc’s (OBIO) raw stochastic average was set at 2.91%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was lower than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.04, while its 200-day Moving Average is $4.24.
